- Helps in controlling blood sugar levels in patients with type 2 diabetes mellitus.
- Reduces the risk of diabetes-related complications such as neuropathy, nephropathy, and retinopathy.
- Improves insulin sensitivity and promotes better glucose uptake by cells.
- Facilitates weight management as part of a comprehensive diabetes care plan.
- Can be used in conjunction with diet and exercise for enhanced glycemic control.
- May help in reducing the need for insulin therapy in some patients.
- Supports overall metabolic health by improving lipid profiles.
Rapilif M 25 Tablet - Strip of 10
Compositions : Mirabegron 25mg + Silodosin 8mg
MRP :
MRP :
Out of stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: IPCA Laboratories Ltd
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Rapilif M 25 Tablet is a pharmaceutical product that combines two active ingredients, Metformin and Glimepiride, to effectively manage blood sugar levels in individuals diagnosed with type 2 diabetes mellitus. This combination works synergistically to enhance glycemic control, making it a vital option for patients who require more than just diet and exercise to manage their condition. Metformin, a biguanide, primarily reduces hepatic glucose production and improves insulin sensitivity, while Glimepiride, a sulfonylurea, stimulates insulin secretion from the pancreatic beta cells. Together, these components help in achieving better overall glycemic control. The tablet is typically prescribed when lifestyle modifications alone are insufficient to maintain optimal blood glucose levels. Rapilif M 25 Tablet is available in a convenient oral dosage form, allowing for easy administration and adherence to treatment regimens. It is essential for patients to understand the importance of consistent medication use alongside dietary adjustments and regular physical activity to achieve the best outcomes in managing their diabetes. The formulation of Rapilif M 25 Tablet is designed to provide a balanced approach to diabetes management, addressing both insulin resistance and secretion deficiencies. As such, it plays a crucial role in the therapeutic landscape for diabetes care, helping patients lead healthier lives while minimizing the risk of complications associated with uncontrolled blood sugar levels.
Product Details
- Metformin decreases hepatic glucose production, leading to lower blood sugar levels.
- Glimepiride stimulates the pancreas to release more insulin, which helps lower blood glucose levels post-meal.
- The combination enhances the body's response to insulin, improving glucose uptake by tissues.
- Together, they work to stabilize blood sugar levels throughout the day.
- Take Rapilif M 25 Tablet orally with a glass of water.
- Dosage is typically prescribed by a healthcare provider based on individual needs.
- Commonly recommended starting dose is one tablet taken once daily.
- It is advisable to take the tablet with meals to minimize gastrointestinal side effects.
- Do not crush or chew the tablet; swallow it whole for optimal effectiveness.
- Regular monitoring of blood glucose levels is essential to adjust dosage as needed.
- Consult your healthcare provider if you miss a dose; do not double up on doses.
- Maintain a balanced diet rich in whole grains, fruits, vegetables, and lean proteins.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise weekly.
- Monitor blood sugar levels regularly to understand how food and activity affect your diabetes management.
- Avoid excessive consumption of sugary foods and beverages that can spike blood sugar levels.
- Stay hydrated by drinking plenty of water throughout the day.
- Consider working with a dietitian or diabetes educator for personalized meal planning.
Safety Advice
Side Effects
- Common side effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain.
- Some patients may experience dizziness or headache as their body adjusts to the medication.
- Serious side effects can include hypoglycemia (low blood sugar), which may present as sweating, confusion, or fainting; seek immediate medical attention if these occur.
- Lactic acidosis is a rare but serious condition associated with Metformin; symptoms include muscle pain, difficulty breathing, and unusual fatigue; seek emergency help if these symptoms arise.
Precautions and Warnings
- Avoid alcohol consumption while taking Rapilif M 25 Tablet as it can increase the risk of lactic acidosis and hypoglycemia.
- Inform your doctor if you are pregnant or breastfeeding before starting this medication.
- Patients with kidney or liver disease should use this medication with caution and under medical supervision.
- Monitor blood glucose levels regularly to prevent hypoglycemia; adjust dosage as necessary based on readings.
- If you experience symptoms of an allergic reaction such as rash, itching, or swelling, seek medical attention immediately.
FAQs
If you miss a dose, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double the dose.
2. Can I take Rapilif M 25 Tablet if I am pregnant?
Consult your healthcare provider before taking Rapilif M 25 Tablet during pregnancy. It is important to manage diabetes effectively during this time.
3. Are there any food interactions with Rapilif M 25 Tablet?
Certain foods may affect blood sugar levels; therefore, it's essential to maintain a consistent diet while taking Rapilif M 25 Tablet.
4. What are the common side effects of Rapilif M 25 Tablet?
Common side effects may include nausea, vomiting, diarrhea, and abdominal discomfort. If these persist or worsen, contact your healthcare provider.
5. Who should avoid using Rapilif M 25 Tablet?
Individuals with severe kidney or liver impairment should avoid using Rapilif M 25 Tablet. Always consult your doctor for personalized advice.
6. How should I store Rapilif M 25 Tablet?
Store Rapilif M 25 Tablet at room temperature away from moisture and heat. Keep it out of reach of children.
Instructions
Directions for Use
Storage and Disposal
More Information
| SKU | 180033 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | IPCA Laboratories Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Rapilif M 25 Tablet is a pharmaceutical product that combines two active ingredients, Metformin and Glimepiride, to effectively manage blood sugar levels in individuals diagnosed with type 2 diabetes mellitus. This combination works synergistically to enhance glycemic control, making it a vital option for patients who require more than just diet and exercise to manage their condition. Metformin, a biguanide, primarily reduces hepatic glucose production and improves insulin sensitivity, while Glimepiride, a sulfonylurea, stimulates insulin secretion from the pancreatic beta cells. Together, these components help in achieving better overall glycemic control. The tablet is typically prescribed when lifestyle modifications alone are insufficient to maintain optimal blood glucose levels. Rapilif M 25 Tablet is available in a convenient oral dosage form, allowing for easy administration and adherence to treatment regimens. It is essential for patients to understand the importance of consistent medication use alongside dietary adjustments and regular physical activity to achieve the best outcomes in managing their diabetes. The formulation of Rapilif M 25 Tablet is designed to provide a balanced approach to diabetes management, addressing both insulin resistance and secretion deficiencies. As such, it plays a crucial role in the therapeutic landscape for diabetes care, helping patients lead healthier lives while minimizing the risk of complications associated with uncontrolled blood sugar levels.
- Helps in controlling blood sugar levels in patients with type 2 diabetes mellitus.
- Reduces the risk of diabetes-related complications such as neuropathy, nephropathy, and retinopathy.
- Improves insulin sensitivity and promotes better glucose uptake by cells.
- Facilitates weight management as part of a comprehensive diabetes care plan.
- Can be used in conjunction with diet and exercise for enhanced glycemic control.
- May help in reducing the need for insulin therapy in some patients.
- Supports overall metabolic health by improving lipid profiles.
- Metformin decreases hepatic glucose production, leading to lower blood sugar levels.
- Glimepiride stimulates the pancreas to release more insulin, which helps lower blood glucose levels post-meal.
- The combination enhances the body's response to insulin, improving glucose uptake by tissues.
- Together, they work to stabilize blood sugar levels throughout the day.
- Take Rapilif M 25 Tablet orally with a glass of water.
- Dosage is typically prescribed by a healthcare provider based on individual needs.
- Commonly recommended starting dose is one tablet taken once daily.
- It is advisable to take the tablet with meals to minimize gastrointestinal side effects.
- Do not crush or chew the tablet; swallow it whole for optimal effectiveness.
- Regular monitoring of blood glucose levels is essential to adjust dosage as needed.
- Consult your healthcare provider if you miss a dose; do not double up on doses.
- Maintain a balanced diet rich in whole grains, fruits, vegetables, and lean proteins.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise weekly.
- Monitor blood sugar levels regularly to understand how food and activity affect your diabetes management.
- Avoid excessive consumption of sugary foods and beverages that can spike blood sugar levels.
- Stay hydrated by drinking plenty of water throughout the day.
- Consider working with a dietitian or diabetes educator for personalized meal planning.
Side Effects
- Common side effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain.
- Some patients may experience dizziness or headache as their body adjusts to the medication.
- Serious side effects can include hypoglycemia (low blood sugar), which may present as sweating, confusion, or fainting; seek immediate medical attention if these occur.
- Lactic acidosis is a rare but serious condition associated with Metformin; symptoms include muscle pain, difficulty breathing, and unusual fatigue; seek emergency help if these symptoms arise.
Precautions and Warnings
- Avoid alcohol consumption while taking Rapilif M 25 Tablet as it can increase the risk of lactic acidosis and hypoglycemia.
- Inform your doctor if you are pregnant or breastfeeding before starting this medication.
- Patients with kidney or liver disease should use this medication with caution and under medical supervision.
- Monitor blood glucose levels regularly to prevent hypoglycemia; adjust dosage as necessary based on readings.
- If you experience symptoms of an allergic reaction such as rash, itching, or swelling, seek medical attention immediately.
If you miss a dose, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double the dose.
2. Can I take Rapilif M 25 Tablet if I am pregnant?
Consult your healthcare provider before taking Rapilif M 25 Tablet during pregnancy. It is important to manage diabetes effectively during this time.
3. Are there any food interactions with Rapilif M 25 Tablet?
Certain foods may affect blood sugar levels; therefore, it's essential to maintain a consistent diet while taking Rapilif M 25 Tablet.
4. What are the common side effects of Rapilif M 25 Tablet?
Common side effects may include nausea, vomiting, diarrhea, and abdominal discomfort. If these persist or worsen, contact your healthcare provider.
5. Who should avoid using Rapilif M 25 Tablet?
Individuals with severe kidney or liver impairment should avoid using Rapilif M 25 Tablet. Always consult your doctor for personalized advice.
6. How should I store Rapilif M 25 Tablet?
Store Rapilif M 25 Tablet at room temperature away from moisture and heat. Keep it out of reach of children.
Directions for Use
Storage and Disposal
| SKU | 180033 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | IPCA Laboratories Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account